At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...

Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

Pioglitazone cut dementia risk by more than half in people with type 2 diabetes who have a history of stroke, per a new study. People with diabetes are about twice as likely to eventually develop ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Most people don't take medication for the side effects. But some Americans are turning to a group of diabetes medications for something other than relief from the disease. Drugs like Ozempic and ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes. Weight ...